| Name | Title | Contact Details |
|---|---|---|
Thomas Janis |
Chief Financial Officer | Profile |
Rebecca O`Loughlin |
Chief People Officer | Profile |
Rebecca O`Loughlin |
Chief People Officer | Profile |
Mohan Ganesan |
Group Chief Financial Officer | Profile |
Erica Smith |
Chief People Officer | Profile |
Assertio Therapeutics, Inc. is an American specialty pharmaceutical company.
Inotek Pharmaceuticals Corporation is a Lexington, MA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
At Shire, we enable people with life altering conditions to lead better lives. We focus on developing and delivering innovative treatments for patients with rare diseases and other specialty conditions.To realize our aspiration to become a leading global biotech, our efforts are concentrated on four key strategic drivers: growth, innovation, efficiency, and people. Our priorities are to drive optimal performance of our existing products, increase patient access to these medicines, and to build our pipeline through research and development and partnerships in order to deliver new medicines to patients.
Septodent is a Cambridge, ON-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Walking Fish Therapeutics, Inc. is a privately held biotechnology company discovering and developing innovative therapeutics that harness the power of B cells as protein factories and immune modulators. Walking Fish has created a broad technology platform addressing enzyme replacement therapies, oncology, autoimmune disease, and recombinant antibody production. The company`s first program, WFX-001, employs B cells as protein factories to generate a deficient enzyme in Fabry disease. Founded in 2019 by Lewis (Rusty) Williams, MD, PhD, the former CSO of Chiron, co-founder of Cor Therapeutics and founder and Chief Executive Officer of Five Prime Therapeutics, the company has assembled a diverse and experienced team of scientists and business leaders who are committed to bringing life-changing and life-saving therapeutics to patients worldwide.